CARBAMAZEPINE AND MACROLIDES - TELITHROMYCIN
The manufacturer predicts that carbamazepine will reduce the levels of telithromycin, and that telithromycin may raise carbamazepine levels.
The manufacturers say to avoid telithromycin use during and for up to 2 weeks after carbamazepine treatment. If concurrent use is essential, monitor carbama- zepine levels and telithromycin efficacy. Carbamazepine toxicity may present as nausea, vomiting, ataxia or drowsiness.
The manufacturers say to avoid telithromycin use during and for up to 2 weeks after carbamazepine treatment. If concurrent use is essential, monitor carbama- zepine levels and telithromycin efficacy. Carbamazepine toxicity may present as nausea, vomiting, ataxia or drowsiness.